The CARI Guidelines Caring for Australians with Renal Impairment. 4. Monitoring proteinuria in patients with suspected or known renal disease

Similar documents
>4000 mg/dl (=20000/(500/100)) >615 mmol/l (=20000/(65*0.5))

Diabetic Nephropathy

Management of New-Onset Proteinuria in the Ambulatory Care Setting. Akinlolu Ojo, MD, PhD, MBA

Evaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands

An unresolved issue: The relationship between spot urine protein-to-creatinine ratio and 24-hour proteinuria

Primary Care Approach to Management of CKD

Chronic kidney disease screening and assessment

The CARI Guidelines Caring for Australasians with Renal Impairment. Blood Pressure Control role of specific antihypertensives

The CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES

QUICK REFERENCE FOR HEALTHCARE PROVIDERS

Supplementary Online Content

ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour

The CARI Guidelines Caring for Australians with Renal Impairment. 5. Classification of chronic kidney disease based on evaluation of kidney function

Summary of Recommendation Statements Kidney International Supplements (2013) 3, 5 14; doi: /kisup

Reducing proteinuria

Creatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Determining the optimal method for proteinuria detection in chronic spinal cord injury

National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register

Supplementary Online Content

The CARI Guidelines Caring for Australians with Renal Impairment. Monitoring patients on peritoneal dialysis GUIDELINES

An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies Howard F M

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Urinary albumin creatinine ratio (ACR) A comparative study on two different instruments

Diabetes and Hypertension

Online Supplementary Appendix

The CARI Guidelines Caring for Australians with Renal Impairment. Specific effects of calcium channel blockers in diabetic nephropathy GUIDELINES

Quality ID #119 (NQF 0062): Diabetes: Medical Attention for Nephropathy National Quality Strategy Domain: Effective Clinical Care

Original Article. Verônica Verleine Hörbe Antunes, Francisco José Veríssimo Veronese and José Vanildo Morales. Introduction

Improved methods of assessing proteinuria in hypertensive pregnancy

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Chronic Renal Failure Followed by Acute Renal Failure

Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine proteincreatinine

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

The relation between estimated glomerular filtration rate and proteinuria in Okayama Prefecture, Japan

Quality of Care in Early Stage Chronic Kidney Disease

H(a)ematuria. FX Keeley Consultant Urologist Bristol Urological Institute

NORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE

Diabetic Nephropathy. Objectives:

Renal Protection Staying on Target

The National Quality Standards for Chronic Kidney Disease

Laboratory Bulletin...

Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care

The CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES

Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of steroid therapy GUIDELINES

A New Approach for Evaluating Renal Function and Predicting Risk. William McClellan, MD, MPH Emory University Atlanta

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Chronic kidney disease (CKD) has received

Study of Micro Albuminuria and Other Parameters in NIDDM Individuals

Chapter 1: CKD in the General Population

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Online clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary

Correlation of Urinary Foam with Proteinuria in Patients with Chronic Kidney Disease

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors

Out of date SUGGESTIONS FOR CLINICAL CARE (Suggestions are based on level III and IV evidence)

Outline. Outline. Introduction CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 8/11/2011

The prevalence of albuminuria among diabetic patients in a primary care setting in Singapore

The CARI Guidelines Caring for Australasians with Renal Impairment. Uric acid GUIDELINES. No recommendations possible based on Level I or II evidence.

A study of predictive value of microalbuminuria in early outcome of non-diabetic patients of acute myocardial infarction

The CARI Guidelines Caring for Australasians with Renal Impairment. Idiopathic membranous nephropathy: use of other therapies GUIDELINES

23-Jun-15. Albuminuria Renal and Cardiovascular Consequences A history of progress since ,490,000. Kidney Center, UMC Groningen

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

URINE DIPSTICK AND SULPHOSALICYLIC ACID TEST. Špela Borštnar UREX 2015, Ljubljana, Slovenia

Elevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC

Higher levels of Urinary Albumin Excretion within the Normal Range Predict Faster Decline in Glomerular Filtration Rate in Diabetic Patients

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

Addressing Chronic Kidney Disease in People with Multiple Chronic Conditions

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of tonsillectomy GUIDELINES

Taking a dip into urinalysis

RENAAL, IRMA-2 and IDNT. Three featured trials linking a disease spectrum IDNT RENAAL. Death IRMA 2

E.Ritz Heidelberg (Germany)

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

EVIDENCE BASED TREATMENT OF IgA NEPHROPATHY. Jonathan Barratt

Pattern of urinary albumin excretion in non-diabetic first-degree relatives of type 2 diabetes mellitus patients

Spot urinary protein creatinine ratio with 24 hour urine protein in hypertensive disorders of pregnancy- a comparative study

The CARI Guidelines Caring for Australians with Renal Impairment. Other criteria for starting dialysis GUIDELINES

Outline. Introduction. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 6/26/2012

Proteinuria (Protein in the Urine) Basics

The CARI Guidelines Caring for Australasians with Renal Impairment

Key Clinical Tips KIDNEY HEALTH AUSTRALIA

Professor Suetonia Palmer

Clinical Laboratory Science: Urinalysis

Prediction of microalbuminuria by using spot urine samples and regression analysis to convert spot microalbumin values to 24 hours microalbuminuria

Diabetes and Kidney Disease. Kris Bentley Renal Nurse practitioner 2018

Alberta Kidney Care Report February Prevalence and Quality of Care in Chronic Kidney Disease

ASSESSMENT OF A POINT-OF-CARE DEVICE FOR MEASURING CREATININE IN A COMMUNITY SCREENING PROGRAM FOR CHRONIC KIDNEY DISEASE

The validity of screening based on spot morning urine samples. detect subjects with microalbuminuria in the general population

CARDIO-RENAL SYNDROME

From single studies to an EBM based assessment some central issues

Proteinuria DR. SANJAY PANDEYA MD. FRCPC.

6/10/2014. Chronic Kidney Disease - General management and standard of care. Management of CKD according to stage (KDOQI 2002)

The CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

Life Science Journal 2014;11(10)

Methven, Shona (2012) Predictors of renal and patient outcomes in chronic kidney disease. MD thesis.

Aggressive blood pressure reduction and renin angiotensin system blockade in chronic kidney disease: time for re-evaluation?

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.

Transcription:

4. Monitoring proteinuria in patients with suspected or known renal disease Date written: February 2003 Final submission: June 2004 Guidelines No recommendations possible based on Level I or II evidence Suggestions for clinical care (Suggestions are based on level III and IV sources) Timed urine collections are recommended when knowledge of absolute level of proteinuria is required. Background There are some issues of concern when protein:creatinine ratio/albumin:creatinine ratio (PCR/ACR) is used to predict accurately the level of proteinuria, firstly with the statistical validity of these studies. Bland and Altman (1986) have demonstrated that correlation measures the strength of the linear association between tests and not the agreement between tests. This becomes increasingly relevant when the actual values are important such as commencing or monitoring response to therapy. There are two studies that have assessed the agreement between tests rather than correlation. Mitchell et al (1993) found excellent correlation between adjusted PCR and 24 hr urine total protein (UTP, r = 0.98, p < 0.0001) but poor agreement. The 95% limits of agreement were between +69% and 43%. In spite of the discrepancy between the absolute value of PCR and the 24 hr UTP, adjusted PCR (adjusted for age, weight, gender) remained a fair discriminator of the relative degree of proteinuria and allowed correct broad classification between 81% at UTP < 150 mg/day and 90% at 1.0-3.5 g/day and 100% at > 3.5 glday. Cundy et al (1992) assessed the agreement between ACR and 24 hr urine albumin excretion (UAE). Again, there was strong correlation between the methods (r = 0.94) but the limits of agreement were wide and the coefficient of variation was 158%. PCR/ACR are semi-quantitative tests that are useful for the broad categorisation of urine protein excretion. The usefulness of random samples to monitor protein excretion over time is unclear. Rodby et al (1995) studied 33 patients who had paired 24 hr and random collections at least 3 months apart, and demonstrated significant discordance between samples in the direction of change. In 6 patients, the PCR increased while the 24 hr UTP

decreased while in 8 other patients, the reverse was true. Further studies to assess this are required. Search strategy Databases searched: MeSH terms and text words for each index test type were combined with text words for the reference standard (ie timed urine collection for proteinuria and albuminuria). The search was carried out in Medline (1966 January Week 1 2003).* (Refer to Appendix 1). Date of search/es: 21 January 2003. What is the evidence? No randomised controlled trials were found on this topic. Summary of the evidence Not possible. What do the other guidelines say? Kidney Disease Outcomes Quality Initiative: Monitoring proteinuria in adults with chronic kidney disease, the protein-to-creatinine ratio in spot urine samples should be measured using: albumin-to-creatinine ratio total protein-to-creatinine ratio is acceptable if albumin-to-creatinine ratio is high (> 500 to 1000 mg/g). Implementation and audit No recommendation. Suggestions for future research No recommendation.

References Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476): 307-10. Cundy TF, Nixon D, Berkahn L et al. Measuring the albumin excretion rate: agreement between methods and biological variability. Diabet Med 1992; 9(2):138-43. Jaeschke R, Guyatt G, Sackett DL. Users guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1944; 271(5): 389-91. Mitchell SC, Sheldon TA, Shaw AB. Quantification of proteinuria: a re-evaluation of the protein/creatinine ratio for elderly subjects. Age Ageing 1993; 22(6): 443-49. Rodby RA, Rohde RD, Sharon Z et al. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis 1995; 26(6): 904-09.

Appendix Search Strategy Table 1 - PICOM Table Question Type Diagnosis Population / Clinical Problem Patients with vascular disease diabetes hypertension immediate relatives of patients with diabetes, hypertension or renal disease Aboriginal and Torres Strait Islanders (if inadequate data general population) Intervention Comparison Outcome(s) (M) Best feasible study design What is the test performance of urine dipstick random urine timed collections eg. overnight Sensitivity/specificity, negative and positive predictive values Compared with 24 hr urine protein/albumin excretion Measure of agreement between tests, correlation between tests Systematic review, crosssectional study Explanatory notes: The draft CARI guideline Prevention of progression of renal disease Early detection of patients with renal disease suggests that the presence of proteinuria and renal impairment should be routinely assessed in patients at increased risk of renal failure including: patients with vascular disease, diabetes or hypertension immediate relatives of patients with diabetes, hypertension, or renal disease Aboriginal and Torres Strait Islanders patients complaining of prostatic symptoms (renal function most applicable) It was considered appropriate that the search be confined to the same populations and be applied in two situations: 1. population screening/ diagnosis (sensitivity and specificity, positive and negative predictive values) 2. guide to disease management (eg. response to therapy) and progression.

Methods The search strategy outlined was used in Medline from 1966 to January 2003. Abstracts were screened by MG, S McT and NI and relevant papers obtained. 1. Reagent strips (1909) 2. dipstick$.tw (894) 3. Nitrites/ (7753) 4. Esterases/ (9519) 5. nitrites.tw. (982) 6. leucocyte esterase$.tw (53) 7. random urine$.tw. (295) 8. (urine and timed collection$).tw. (23) 9. timed urine collection$.tw. (103) 10. or/1-9 (20469) 11. ( 24 or time$ or hour$).tw (1377513) 12. 10 and 11 (2688) 13. Proteinuria/ (12666) 14. (proteinuria or urinary protein).tw. (15281) 15. Albuminuria/ (5532) 16. (albuminuria or urinary albumin).tw. (3794) 17. 13 and 14 (6613) 18. 15 and 16 (2520) 19. 12 and 17 (73) 20. 12 and 18 (53) 21. from 19 keep 1-73 (73) 22. from 20 keep 1-58 (58) The reference lists of relevant articles and reviews were hand searched and relevant additional papers located. The quality of the studies was assessed according to the methodology of *Jaeschke et al (1994). However, the quality of the data was generally poor and studies were included if they met the following criteria: (1) the studies investigated the use of dipstick, morning or random urine for investigation of proteinuria or albuminuria, (2) the comparator was a 24 hour urine protein or overnight timed collection, and (3) test performance could be determined from the study. Studies were included from both hospital and ambulatory settings. Only English language (or abstract) papers were included. We did not seek unpublished data.